CR.LQTH002Cx-A17
NUIGi038-B-1
General
iPSC Line |
|
| hPSCreg name | NUIGi038-B-1 |
| Cite as: | NUIGi038-B-1 |
| Alternative name(s) |
CR.LQTH002Cx-A17
|
| iPSC line type | Human induced pluripotent stem cell (hiPSC) |
| Similar iPSC lines |
NUIGi038-B (LQTH002Cx) NUIGi038-B-2 (CR.LQTH002Cx-A21) NUIGi038-B-3 (CR.LQTH002Cx-3A15) NUIGi038-B-4 (CR.LQTH002Cx-3A18) NUIGi038-A (LQTH002C4) NUIGi038-C (LQTH002C1) UCSDi001-A-2 (LQT3_35_iPSC_P15, UCSD243i-LQT3-1) UCSDi001-A-3 (LQT3_4_28_Homo_52_iPSC_P15, UCSD244i-LQT3-2) UCSDi001-A-5 (UCSD246i-CNTL-2, T036_SNP1_Het_3_iPSC_P16_R01) WAe009-A-1H (MYL3-KO) UCSDi001-A-1 (UCSD242i-LQT1-1, LQT1_2_5_iPSC_P17) UCSDi001-A-4 (UCSD245i-CNTL-1, T036_SNP1_Het_1_iPSC_P15_R01) WAe009-A-36 (JPH2-KO) BBANTWi012-A-1 (TTN_E48_V4623*) BBANTWi012-A-2 (iPSC_FB_F19901C3_TTN_E48_L4612*) BBANTWi012-A-3 (iPSC_FB_F19901C3_TTN_E357_E33459*_N33456N_C30) BBANTWi012-A-4 (iPSC_FB_F19901C3_TTN_E357_V33467*_N33456N_C3) WAe009-A-1E (TBX20-KO) IRFMNi003-A-3 (KO PKD1#16) IRFMNi003-A-4 (KO PKD1#5) IRFMNi003-A-1 (KO PKD2#17) WAe009-A-62 (KCNQ1 KO) IRFMNi003-A-2 (KO PKD2#36) LUMCi004-A-5 (LU99_SCN5A-R282H_cis) LUMCi004-A-6 (LU99_SCN5A-R282H_trans) UKEi001-A-1 (CRYABhom) BBANTWi012-A-5 (iPSC_F199001_C3_CRISPR_CACNA1C_T330M_HMZ_C6) BBANTWi012-A-6 (iPSC_F199001_C3_CRISPR_CACNA1C_T330M_HTZ_C11.2) WAe009-A-1Y (TRPV2-KO) IMBAi001-A-1 (HD.1 ARID1B+/- clone 3b (XX)) |
| Last update | 12th August 2021 |
| User feedback | |
Provider |
|
| Generator | National University of Ireland Galway (NUIG) |
| Owner | National University of Ireland Galway (NUIG) |
| Derivation country | Ireland |
External iPSC Databases |
|
| BioSamples | SAMEA7462438 |
General iPSC Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
iPSC Genetic Modification
| Disease/phenotype related modifications |
|
Donor Information
General Donor Information |
|
| Sex | female |
| Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA5945671 |
Ethics
Also have a look at the ethics information for the parental line
NUIGi038-B
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
iPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
NUIGi038-B.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
iPSC Culture Conditions
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
|
| Medium |
Essential 8™ Flex
|
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| SOX2 |
Yes |
|
||||
| NANOG |
Yes |
|
Differentiation Potency
Microbiology / Virus Screening |
|
| Mycoplasma | Negative |
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
CR.LQTH002Cx-A17 SNP
Karyotyping method:
Molecular karyotyping by SNP array
http:// |
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.